3 minutes ago, 2:32am (ET) 05/01/2013 DatamonitorAduro BioTech, Inc., a biopharmaceutical company, has announced collaboration with the Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination ...
[Published Zecco - May 01 2013]